The global value of vaccination

被引：246

作者：

Ehreth, J ^{[1
]}

机构：

[1] Tulane Univ, Medtron Europe SA, Dept Hlth Syst Management, CH-1131 Tolochenaz, Switzerland

来源：

VACCINE | 2003年 / 21卷 / 7-8期

关键词：

cost-effectiveness; burden of disease; vaccination;

D O I：

10.1016/S0264-410X(02)00623-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

While most agree that vaccination is one of the most important public health practices, vaccines continue to be underused and undervalued, and vaccine-preventable diseases remain a threat to world health. Perhaps one reason this Cap remains is that decision-making generally is made on a vaccine-by-vaccine basis. There has been less attention to the value of vaccination in general. To more clearly identify this value, this paper reviews the cost-effectiveness literature and calculates the annual benefits of vaccination on a global scale. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：596 / 600

页数：5

共 12 条

[1]

ANDRUSJK, 2001, VACCINOLOGY IMMUNIZA

[2]

[Anonymous], 1994, MMWR

[3]

Breiman RF, 2001, CLIN INFECT DIS, V32, P283, DOI 10.1086/318461

[4]

*CDC, IMM 2001 ANN REP CTR

[5]

Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1124

[6]

Dietz V, 1996, B WORLD HEALTH ORGAN, V74, P619

[7]

HEYMANN DL, 2000, COMMUNICATION 0629, P8

[8]

Swartz J, 1999, SUSTAINING EFFECTIVE

[9] BENEFITS, RISKS AND COSTS OF IMMUNIZATION FOR MEASLES, MUMPS AND RUBELLA [J].

WHITE, CC ;

KOPLAN, JP ;

ORENSTEIN, WA .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1985, 75 (07) :739-744

[10]

*WHO, 2001, DIS ER EL GOALS

← 1 2 →